News Releases

Share this

Health and Behavior

Study identifies mechanism linking stress to physical illness, aging

07/15/2008

FINDINGS:

Every cell contains a tiny clock called a telomere, which shortens each time the cell divides. Short telomeres are linked to a range of human diseases, including HIV, osteoporosis, heart disease and aging. Previous studies have shown that an enzyme within the cell, called telomerase, keeps immune cells young by preserving their telomere length and ability to continue dividing. UCLA scientists found that the stress hormone cortisol suppresses immune cells' ability to activate their telomerase. This may explain why the cells of persons under chronic stress have shorter telomeres.

"When the body is under stress, it boosts production of cortisol to support a 'fight or flight' response," said study author Rita Effros. "If the hormone remains elevated in the bloodstream for long periods of time, though, it wears down the immune system. We are testing therapeutic ways of enhancing telomerase levels to help the immune system ward off cortisol's effect. If we're successful, one day a pill may exist to strengthen the immune system's ability to weather chronic emotional stress."

IMPACT:

The study reveals how stress makes people more susceptible to illness. The findings also suggest a potential drug target for preventing damage to the immune systems of individuals suffering from long-term stress — such as caregivers to chronically ill family members, soldiers, air traffic controllers, astronauts and people who drive long daily commutes.

AUTHOR:

Rita Effros is a professor of pathology and laboratory medicine at the David Geffen School of Medicine at UCLA and a member of UCLA's Jonsson Cancer Center, the UCLA Molecular Biology Institute and the UCLA AIDS Institute.

JOURNAL:

The research was published in the May 2008 issue of the peer-reviewed journal Brain, Behavior and Immunity.

FUNDING:

The study was supported by the National Institute on Aging, the National Institute of Allergy and Infectious Diseases, the Geron Corp. and TA Therapeutics Ltd.